Literature DB >> 15448323

Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study.

William Cusick1, Jacquelyn Provenzano, Christopher A Sullivan, Francene M Gallousis, John F Rodis.   

Abstract

OBJECTIVE: To develop normative data for nasal bone length between 11 and 20 weeks' gestation and to assess the utility of nasal bone hypoplasia in the detection of fetal aneuploidy in the second trimester.
METHODS: Well-dated, nonanomalous fetuses were examined between 11 and 20.9 weeks' gestation. The nasal bone was assessed and measured, and normative data from 11 to 20 weeks' gestation were determined. The nasal bone lengths in fetuses with confirmed aneuploidy were compared with the normative data.
RESULTS: The fetal nasal bone length increased linearly with advancing gestational age. Nomograms including the 10th, 50th, and 90th percentiles were created. Nasal bone hypoplasia was seen in 6 of 6 cases of fetal trisomy in the second trimester.
CONCLUSIONS: Nasal bone hypoplasia in the early second trimester identifies a cohort of fetuses at high risk for aneuploidy.

Entities:  

Mesh:

Year:  2004        PMID: 15448323     DOI: 10.7863/jum.2004.23.10.1327

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  9 in total

1.  Normative curves of fetal nasal bone length for the ethnic Chinese population.

Authors:  W-H Chiu; T-H Tung; Y-S Chen; W-H Wang; S-M Lee; S-C Horng; F-Y Yang
Journal:  Ir J Med Sci       Date:  2010-07-09       Impact factor: 1.568

Review 2.  First trimester ultrasound tests alone or in combination with first trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 3.  First and second trimester serum tests with and without first trimester ultrasound tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2017-03-15

Review 4.  Second trimester serum tests for Down's Syndrome screening.

Authors:  S Kate Alldred; Jonathan J Deeks; Boliang Guo; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2012-06-13

5.  Sonographic measurement of ear length among normal fetuses of pregnant Igbo women in port Harcourt, Nigeria.

Authors:  Felicitas Idigo; Kingsley Ajibo; Angel-Mary Anakwue; Uloma Nwogu; Ebbi Robinson
Journal:  Afr Health Sci       Date:  2021-03       Impact factor: 0.927

6.  Chromosomal Microarray Analysis for the Prenatal Diagnosis in Fetuses with Nasal Bone Hypoplasia: A Retrospective Cohort Study.

Authors:  Hailong Huang; Meiying Cai; Wei Ma; Na Lin; Liangpu Xu
Journal:  Risk Manag Healthc Policy       Date:  2021-04-14

7.  Nasal bone to nasal tip length ratio for describing nasal bone hypoplasia and predicting trisomy 21.

Authors:  Emre Ekmekci; Emine Demirel; Sefa Kelekci
Journal:  Arch Med Sci       Date:  2019-06-06       Impact factor: 3.318

Review 8.  First trimester serum tests for Down's syndrome screening.

Authors:  S Kate Alldred; Yemisi Takwoingi; Boliang Guo; Mary Pennant; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-11-30

Review 9.  Urine tests for Down's syndrome screening.

Authors:  S Kate Alldred; Boliang Guo; Yemisi Takwoingi; Mary Pennant; Susanna Wisniewski; Jonathan J Deeks; James P Neilson; Zarko Alfirevic
Journal:  Cochrane Database Syst Rev       Date:  2015-12-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.